Marshall Wace
AGL icon

Marshall Wace’s Agilon Health AGL Stock Holding History

Marshall Wace’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.2M Buy
+468,293
New +$30.7M 0.04% 382
2026
Q1 		– Sell
-5,593
Closed -$96.5K – 3144
2025
Q4 		$96.5K Buy
+5,593
New +$108K ﹤0.01% 2718
2025
Q3 		– Sell
-59,365
Closed -$3.41M – 2846
2025
Q2 		$3.41M Buy
59,365
+57,756
+3,590% +$4.63M ﹤0.01% 1318
2025
Q1 		$174K Buy
+1,609
New +$140K ﹤0.01% 2432
2024
Q4 		– Sell
-695
Closed -$68.3K – 2539
2024
Q3 		$68.3K Buy
+695
New +$89.7K ﹤0.01% 2401
2024
Q2 		– Sell
-9,119
Closed -$1.39M – 2501
2024
Q1 		$1.39M Buy
+9,119
New +$1.52M ﹤0.01% 1522

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Marshall Wace's AGL Position: Q2 2026 in Review

Marshall Wace opened a new position in Agilon Health (AGL) in Q2 2026: 468,293 shares worth $50.2M. The stake represents 0.04% of the portfolio and ranks #382 among its holdings. This is a return to the name: Marshall Wace previously reported a position in AGL as recently as Q4 2025.

Marshall Wace first reported a position in AGL in Q1 2024 and has held it in 6 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Marshall Wace held 468,293 shares of Agilon Health worth $50.2M as of Q2 2026.
  • Agilon Health was a new Marshall Wace position in Q2 2026.
  • Agilon Health made up 0.04% of Marshall Wace's portfolio in Q2 2026, its #382 holding.
  • Marshall Wace first reported a position in Agilon Health in Q1 2024 and has held it in 6 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.